Infections in Patients Receiving OKT3 Monoclonal Antibody for Cardiac Rejection

Orthoclone OKT3 (muromonab-CD3), a murine monoclonal antibody that virtually eliminates circulating T cells and inhibits medullary lymphocyte function, has recently been found effective in reversing stubborn severe allograft rejection after heart transplantation. To determine the influence of OKT3 t...

Täydet tiedot

Bibliografiset tiedot

Julkaisussa:	Tex Heart Inst J
Päätekijät:	Sinnott, John T., Cullison, James P., Sweeney, Michael S., Weinstein, Samuel S.
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	Texas Heart Institute 1988
Aiheet:	Clinical Investigation
Linkit:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC324800/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/15227260/
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!